Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Abacavir & Didanosine-Important Safety Information from GlaxoSmithKline and Bristol-Myers Squibb as approved by the IMB

23 April 2008

Please find herewith an important safety communication from GlaxoSmithKline and Bristol-Myers Squibb on results pertaining to abacavir and didanosine from the D:A:D Study (Data Collection of Advere effects of anti-HIV Drugs Study).

Abacavir sulfate -containing medicinal products (Ziagen Tablets and Oral Solution; Kivexa Tablets; Trizivir Tablets)

Didanosine -containing medicinal products (Videx Gastro-resistant capsules)





Date Printed: 21 May 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971